Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating tumor cells in solid tumor in metastatic and localized stages.
Maestro LM, Sastre J, Rafael SB, Veganzones SB, Vidaurreta M, Martín M, Olivier C, DE La Orden VB, Garcia-Saenz JA, Alfonso R, Arroyo M, Diaz-Rubio E. Maestro LM, et al. Among authors: alfonso r. Anticancer Res. 2009 Nov;29(11):4839-43. Anticancer Res. 2009. PMID: 20032444 Free article.
Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.
Perez-Villamil B, Romera-Lopez A, Hernandez-Prieto S, Lopez-Campos G, Calles A, Lopez-Asenjo JA, Sanz-Ortega J, Fernandez-Perez C, Sastre J, Alfonso R, Caldes T, Martin-Sanchez F, Diaz-Rubio E. Perez-Villamil B, et al. Among authors: alfonso r. BMC Cancer. 2012 Jun 19;12:260. doi: 10.1186/1471-2407-12-260. BMC Cancer. 2012. PMID: 22712570 Free PMC article.
A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours.
Sastre J, Paz-Ares L, Carcas A, Alfonso R, Grávalos C, Frías J, Guerra P, Pronk L, Cortés-Funes H, Díaz-Rubio E. Sastre J, et al. Among authors: alfonso r. Cancer Chemother Pharmacol. 2005 May;55(5):453-60. doi: 10.1007/s00280-004-0915-x. Epub 2004 Oct 26. Cancer Chemother Pharmacol. 2005. PMID: 15818508 Clinical Trial.
Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
Sastre J, Serrano JJ, Fernández C, Ramirez C, Ortega L, García-Paredes B, Corona J, Alfonso R, Córdoba S, Díaz-Rubio E. Sastre J, et al. Among authors: alfonso r. Clin Colorectal Cancer. 2016 Jun;15(2):128-34. doi: 10.1016/j.clcc.2015.08.001. Epub 2015 Aug 24. Clin Colorectal Cancer. 2016. PMID: 26385572 Clinical Trial.
Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.
Giaccone G, González-Larriba JL, van Oosterom AT, Alfonso R, Smit EF, Martens M, Peters GJ, van der Vijgh WJ, Smith R, Averbuch S, Fandi A. Giaccone G, et al. Among authors: alfonso r. Ann Oncol. 2004 May;15(5):831-8. doi: 10.1093/annonc/mdh188. Ann Oncol. 2004. PMID: 15111354 Free article. Clinical Trial.
131 results